John Green
Credit - Lee Klafczynski—The New York Times/Redux
Best-selling author John Green is on a mission to make the world suck less. At least, that was the original impetus behind his aptly-named Foundation to Decrease World Suck (FTDWS), the nonprofit he started in 2007 with his brother and fellow Vlogbrothers YouTube channel creator, Hank. However, he says, if you had told them then that FTDWS would become 'a real charity that would go on to raise real tens of millions of dollars,' they might have called it something different.
Still, the name works, as it gets right to the root of what the Greens are striving to do by awarding a total of more than $10 million in grants to dozens of charities since 2012—from perennial recipients Partners in Health and Save the Children to 30-plus other organizations recommended by the participants of the brothers' annual 48-hour telethon-style fundraiser Project for Awesome (P4A). In February, the most recent P4A event raised nearly $3.8 million for an array of nonprofits.
'We used to try to have a measurement of global suck,' Green says. 'I've come to understand you can't really quantify it that way. But you can quantify what makes things better, which is more people having access to health care, education, professional opportunities, etc.'
While public health issues have long been a focus of Green's philanthropic efforts, more recently, he has turned his attention to one global health crisis in particular: tuberculosis. In 2019, during an eye-opening visit to a hospital in Sierra Leone, Green saw firsthand the challenges facing patients and doctors fighting what remains the deadliest infectious disease in the world—despite being completely curable, when treated with sufficient resources. According to the World Health Organization's most recent report, an estimated 1.25 million people died from TB in 2023 alone.
When he returned home from the trip, Green says he began regularly reading and writing about the topic, an undertaking that eventually resulted in his second nonfiction release, Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection. The book debuted at No. 1 on the New York Times best-seller list following its March 18 publication, with a first run of 500,000 copies.
'Tuberculosis has had such a profound impact on human history,' he says. 'This is a disease that has probably killed around one in seven people who've ever lived, and infected many more than that.'
Last year, Green announced he and his family would donate $1 million annually to help fund the work being done to fight tuberculosis in the Philippines, the country with the fourth-highest burden of TB globally. This commitment is part of a larger project Green is involved with that will see a coalition of government agencies and public health advocates provide over $100 million in funding for comprehensive TB care in Ethiopia and the Philippines over the next four years. In 2023, he also publicly rallied his nearly 3.9 million YouTube subscribers to petition Johnson & Johnson to lower the cost of the tuberculosis treatment bedaquiline, which the company did.
Although Green is best known for his massively popular young adult fiction, particularly his 2012 juggernaut The Fault in Our Stars, he says it's his humanitarian work that makes him feel like he's using his platform in a meaningful way. As he puts it, 'What's the point, otherwise?'
Write to Megan McCluskey at megan.mccluskey@time.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Tom's Guide
5 hours ago
- Tom's Guide
I'm a personal trainer — this physiotherapist's 5 back exercises for ages 55+ are a game-changer for flexibility and pain relief
Back-strengthening exercises are crucial for improving posture, building spine and shoulder stability and reducing the likelihood of developing posture-related injuries. A strong back can even improve exercise performance, reduce hunching and help you avoid muscle weaknesses related to inactivity. The best way to target your back muscles is by using a series of pull exercises combined with mobility. Thanks to a physiotherapist, you can now try five of the best back exercises for ages 55+ to help you build flexibility and improve pain relief. Here they are. Before we dive into the exercises themselves, I want to introduce you to Shrey Vazir, whose easy-to-follow YouTube channel has become a small obsession of mine recently, especially as I regularly train my dad, who is in his 70s. Vazir focuses on an important age category — the over 50s — which is roughly the age at which sarcopenia (muscle mass loss) begins to accelerate. As a result, this is also around the time to be making a strength and resistance program a regular and consistent addition to your daily routine to avoid muscle and bone density loss and prevent pain and injury. Vazir is considered an advanced physiotherapist specializing in low back pain, and his five favorite and simple back pain exercises highlight two key areas: strengthening the muscles of the core, hips, legs and surrounding the spine, plus beginner-friendly stretches to improve flexibility. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. It's worth mentioning that while stretching for flexibility offers short-term improvements, you may find you're back to square one the next day. True flexibility from stretching alone is a bit of a unicorn — long-term change comes from a smart and efficient combination of targeted stretches, mobility exercises and strengthening. With a mass of misinformation available on social media, it's important to find someone you can trust when deciding on the best exercise routine for you. I'm a firm believer that you should be lifting weights (even if it's your bodyweight only) and keep moving well into your later years. In short, don't let someone tell you that hitting a certain age means you need to switch up your routine entirely. Yes, we do have to work against the natural changes in hormones, metabolism and body composition as we age. But I know plenty of people over 50 who are stronger and fitter than they were in their 20s. According to this video, the exercises are gentle and are recommended by Vazir at his clinic in Toronto, Canada. You can modify them if they are too easy or too difficult. Watch the video below for his demonstrations, guidelines and suggestions for scaling, plus sets and reps. This is considered an 'easy' stretching exercise you can perform on your back. Simply take your knee or knees up to your chest and hold behind your leg or legs to draw them closer. Focus on keeping your lower back supported throughout. Vazir recommends 5 sets per leg and hold for 10 seconds each time. Also considered a beginner-friendly move, you'll just need a chair or bench to sit on. From here, Vazir guides you to slightly open your legs and place your feet apart, then place your hands on your thighs or between your legs and slowly slide them downward as you bend forward to stretch out your lower back. Try 10 reps with a 5-second hold each time. The first strengthening exercise on Vasir's list is the crunch, which has been modified for a beginner-friendly version. Seated on a bench or chair, Vazir asks you to cross your arms over your chest, squeeze your stomach, then drive your chest forward toward your thighs. We offer some crunch variations here if this exercise feels too easy. Repeat for 2 sets of 10 reps. On your back, tighten your stomach and draw your belly button toward your spine (activation), then hold that tension and lift your knee into the air, lower it and repeat on the other side. Aim for 2 to 3 sets of 10 reps (5 per leg) or lift both legs together if you prefer. We love a dead bug exercise, and so does Vazir. Lay on the floor — legs lifted to 90 degrees and arms extended above your chest. One at a time, you'll extend one arm and the opposite leg, then return to center and switch sides. If you prefer, you could just hold the dead bug position without moving your arms and legs. You could also try just arms, just legs, or even one arm and one leg (in a hold) at a time — Vazir demonstrates your options. Hold for 10 to 30 seconds and repeat 3 sets.


Miami Herald
14 hours ago
- Miami Herald
New to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor Platforms
NEW YORK CITY, NEW YORK / ACCESS Newswire / June 5, 2025 / New to The Street, the nation's leading multi-platform financial news show, today announced it has signed a 12-part media partnership with NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company focused on life-saving therapies for patients with suicidal depression, PTSD, and chronic pain. The partnership will feature monthly televised interviews with NRx CEO Dr. Jonathan Javitt, providing updates from the front lines of biotech innovation. As part of the comprehensive campaign, New to The Street will also produce earned media placements on ABC, NBC, and CBS affiliates, a full suite of nationally aired TV commercials, and premium outdoor billboard exposure in Times Square and throughout the NYC Financial District. The series begins airing later this month on Fox Business and Bloomberg Television as sponsored programming, reaching more than 245 million homes weekly across the U.S. and Middle East. Episodes will also stream on New to The Street's YouTube channel, which now exceeds 2.5 million subscribers, and be supported by billboard takeovers in Times Square and full media amplification through the NewsOut™ and platforms. About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for treating central nervous system disorders. Its lead investigational drug, NRX-101, has been granted FDA Breakthrough Therapy and Fast Track Designation for suicidal bipolar depression. The company is also pursuing accelerated approval for preservative-free IV ketamine (NRX-100) and advancing additional treatments for PTSD, chronic pain, and UTIs. Learn more at About New to The Street New to The Street is a leading branded content TV series that features innovative public and private companies on national television, including Fox Business and Bloomberg Television. With more than 2.52 million YouTube subscribers, a reach of 245 million TV households, and a powerful outdoor media footprint, the platform offers unmatched exposure across digital, television, and out-of-home channels. Learn more at Media Contact:Monica BrennanPR Coordinator, New to The StreetEmail: Monica@ SOURCE: New To The Street


Indianapolis Star
15 hours ago
- Indianapolis Star
New to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor Platforms
NEW YORK CITY, NEW YORK / ACCESS Newswire New to The Street, the nation's leading multi-platform financial news show, today announced it has signed a 12-part media partnership with NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company focused on life-saving therapies for patients with suicidal depression, PTSD, and chronic pain. The partnership will feature monthly televised interviews with NRx CEO Dr. Jonathan Javitt, providing updates from the front lines of biotech innovation. As part of the comprehensive campaign, New to The Street will also produce earned media placements on ABC, NBC, and CBS affiliates, a full suite of nationally aired TV commercials, and premium outdoor billboard exposure in Times Square and throughout the NYC Financial District. 'Our mission has always been to save lives with science,' said Jonathan Javitt, MD, MPH, Founder and CEO of NRx Pharmaceuticals. 'Partnering with New to The Street enables us to share the life-saving potential of NRX-101 and our broader pipeline with a national audience, at a pivotal moment in our regulatory and commercial path.' 'We are proud to bring NRX's critical work to our global audience,' said Vince Caruso, Co-Founder and CEO of New to The Street. 'This series will spotlight a company on the front lines of neuroscience and public health, and exemplifies our commitment to covering stories that matter-with scale, credibility, and impact.' The series begins airing later this month on Fox Business and Bloomberg Television as sponsored programming, reaching more than 245 million homes weekly across the U.S. and Middle East. Episodes will also stream on New to The Street's YouTube channel, which now exceeds 2.5 million subscribers, and be supported by billboard takeovers in Times Square and full media amplification through the NewsOut™ and platforms. About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for treating central nervous system disorders. Its lead investigational drug, NRX-101, has been granted FDA Breakthrough Therapy and Fast Track Designation for suicidal bipolar depression. The company is also pursuing accelerated approval for preservative-free IV ketamine (NRX-100) and advancing additional treatments for PTSD, chronic pain, and UTIs. Learn more at About New to The Street New to The Street is a leading branded content TV series that features innovative public and private companies on national television, including Fox Business and Bloomberg Television. With more than 2.52 million YouTube subscribers, a reach of 245 million TV households, and a powerful outdoor media footprint, the platform offers unmatched exposure across digital, television, and out-of-home channels. Learn more at SOURCE: New To The Street View the original press release on ACCESS Newswire